CBX7 and lung carcinoma: Finally, CBX7 is proposed to play an anti-oncogenic role as measured by proliferation [28], and invasion [29], and CBX7 loss results in highly malignant phenotypes and poor prognoses in other entities (colon, bladder, pancreas, breast, liver and lung cancer) [30–34].